版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
PluripotentStemCells
andReprogrammingYingJinInstituteofHealthSciencesShanghaiInstitutesofBiologicalSciences,CAS/ShanghaiJiaoTongUniversitySchoolofMedicineyjin@Contents★
Concept
★EmbryonicStemCells
★Reprogramming
Contents★Concept
★
EmbryonicStemCells
★Reprogramming
Whatarestemcells?◆
Reproduceitself(self-renewal);◆Generateoneormoredifferentiateddescendantcelltypes;◆Functionallyreconstituteanorganorawholeorganism.SymmetricdivisionAsymmetricdivisionSomaticCellBlastocystImplantationEmbryonicdevelopmentPostnataldevelopmentAdultThesecellswilldifferfromoneanotherinsignificantways:6●
Methylation●Regulatorygeneexpression●X-inactivation●Positionalinformation●Imprintingstatus●MarkerexpressiontotipotentpluripotentmultipotentorunipotentEmbryonicstemcells,ESCellsSomaticstemcellsFetaltissuestemcells
AdulttissuestemcellsInducedpluripotentstemcells(iPScells)Themoststudiedstemcellsinclude:Contents★
Concept
★EmbryonicStemCells
★Reprogramming
Embryonicstemcells:◆
Derivationandculture◆
Characterization◆
DifferentiationEmbryonicstemcells(ESCs)Derivedfrominnercellmass(ICM)ofblastocyst.ThefirsthumanESClinewasestablishedin1998byJamesA.Thomson.
Science
282:1145,1998ICMAhumanEScellcolonyonfeederlayerJamesThomson,Ph.D.StemCellandRegenerativeMedicineCenterUniversityofWisconsinSirMartinJohnEvansisaBritishscientistwho,withMatthewKaufman,wasthefirsttoculturemiceembryonicstemcellsandcultivatetheminalaboratoryin1981.Heisalsoknown,alongwithMarioCapecchiandOliverSmithies,forhisworkinthedevelopmentoftheknockoutmouseandtherelatedtechnologyofgenetargeting,amethodofusingembryonicstemcellstocreatespecificgenemodificationsinmice.In2007,thethreesharedtheNobelPrizeinPhysiologyorMedicineinrecognitionoftheirdiscoveryandcontributiontotheeffortstodevelopnewtreatmentsforillnessesinhumans.EmbryonicGermCells(EGCs)Derivedfromfetaltissue,culturedfromtheprimordialgermcells(PGC)ofthegonadalridgeoffetus.PGCsareembryonicprecursorsofthegametes.ThefirsthumanEGcelllinesweregeneratedbyDr.JohnD.Gearhartin1998.Proc.Natl.Acad.Sci.USA95:13726,1998AhumanEGCColonyFeederlayerJohnD.Gearhart,Ph.D.StemCellBiologyProgramJohnsHopkinesUniversitySchoolofMedicinePerelman
SchoolofMedicine
attheUniversityofPennsylvaniaMouseearlydevelopmentE3.5MouseESCderivationFlushembryos(day3.5)fromtheuterinehorns;PlacethemindividuallyontofeederlayerinEScellculturemedium.Theembryoshatchfromthezonapellucidaandattachtofeederlayerbymigrationofthetrophoblastcells.WhenICM–derivedclumphasenlargedenough,dislodgeitfromtheunderlyingsheetoftrophoblastcellsbydrawnpasteurpipette.UsethepipettetodisaggregateEScellclumpintosmalleraggregates.Transferthesmallclumpintoafreshdishcontainingfeederlayer.Generally,after2days,primarycoloniesofcellswillvisible.Discretecoloniesofastemcellmorphologyareselectivelyremovedafterupto7-8daysofcultureandthendissociatedinmicrodropsoftrypsin/EDTA,andpassagedintofreshfeederwell(keepthecelldensityhigh).SmallnestsofEScellsappearwithin2-3daysofsubcultureandcanbeexpanded3-5dayslaterbytrypsinizingthewholewellandtransferringitscontentsontoalargerfeederdish.AnestablishedEScelllinerequirecarefulsubcultureat2-3dayintervals.MouseEScellmediumissupplementedwith
serum
and
leukemiainhibitoryfactor(LIF).◆FeedercellsandserumFeedercellsprovideleukemiainhibitoryfactor(LIF)Serumprovidesbonemorphogeneticproteins(BMPs)◆Feeder-andserum-freeLIFandBMP◆
LIF-andBMP-free(2i)Thefibroblastgrowthfactor/extracellularsignal-relatedkinase(Fgf/Erk1/2)inhibitorGlycogensynthasekinase3(GSK3)inhibitorCultureofmouseESCsSun,etal.Sun,etal.HumanearlydevelopmentInvitrodevelopmentofIVF體外受精frozenembryos
HumanearlyembryosThephotoisprovidedbyprofessorFengofRplementAnti-humanserumantibodyImmunosurgeryABCEScellsBlastocystReubinoffetal.,2000MichaelAmitetal,JAnat.200:225,2002+Ab+CDerivationofthreenewChinesehumanEScelllines.(A)MorphologyofasurplushumanblastocystfromtheIVFclinics;(B)PrimaryICMoutgrowth(Passage0);(C)Typicalundifferentiatedcoloniespassagedbymechanicalsplitting(Passage5);(D)HighermagnificationofahumanESCcolonypassagedbymechanicalsplitting(Passage9).MechanicalremovaloftrophectodermP0P5P9Lietal.(2010)InvitroCell&Dev.Biol.
–Animal46:186-191.CultureofhumanESCsFeedercells(producingActivin激活素A):basicfibroblastgrowthfactor(bFGF)Passcells,notsinglecells
(enzymes,ormechanicalsplitorcombinationofenzymeandmanualsplitting)InthepresenceofRockinhibitor絲氨酸蘇氨酸蛋白激酶,singlecellOKTrypsin胰蛋白酶-singlecellsAccurase-singlecellsDispase分散酶-clumpsCollagenase膠原酶:feedercellsMechanicalpassageprocedureofhumanEScells.Typicalundifferentiatedcolonieswereseparatedfromfeederlayersusingglassneedles.Thencolonieswerecuthorizontally,andthenverticallytoformuniformclumpsandtransferredontonewlypreparedfeederlayers.Feeder-freeculturehEScellsFeedercellsderivedfromhumantissue:Fetalmuscle,fetalskinAdultfallopiantubuleepithelialcellsForeskinfibroblastAdultmarrowcellsAdultlungUterineendometriumhEScellderivedfibroblast胎兒:肌肉皮膚成人:上皮,子宮內(nèi)膜,包皮纖維原細(xì)胞,非胚胎干細(xì)胞來源:纖維原細(xì)胞NatureBiotech2006DerivationofhESCsindefinedconditionsTeSR1mediumcontaining:bFGF,LiCl氯化鋰,GABAγ氨基丁酸,pipecolicacid哌丁酸,andTGFb轉(zhuǎn)化生長因子,成纖維細(xì)胞生長因子
-sufficienttosupportfeeder-independenthESCculture.Thehumanmatrix-coatedplateswerecomposedof:
hCollagenIV膠原蛋白4,hVitronectin玻璃黏連蛋白,hFibronectin纖維粘連蛋白,andhLaminin層粘連蛋白
JamesAThomson,NatureBiotechnology20062006EstablishmentofhumanfeedercelllineswithoutanimalcomponentsBasalCultureMedium/HumanSerum/HumanGelatin/HumanTrypsinSHhES6SHhES7SHhES8DerivationofXeno-freeHumanESCellLinesLietal.,unpublished3Linesfrom32EmbryosBasicCharacteristicsofESCells1.Karyotypicallynormal;2.Proliferateinvitroindefinitelyunderwell-definedcultureconditions;3.Mostofcellsrecoverafterfreezingandthawing;4.Differentiateintoavarietyofcelltypesinvitroandinvivo.Science300:913,2003Reproduceitself(self-renewal)*
Indefinitelyproliferation(>70passages);*Karyotypicanalysis;(GlobalSNPScan)*MarkersforundifferentiatedEScells;*Telomeraseactivity;*Colonyformingassay.Nature.2007Nov22;450(7169):497-502.Science300:913,2003MolecularmarkersofundifferentiatedhEScellsSSEA-4TRA-1-60
SSEA-1Oct-4AKPTRA-1-81Sun,etal.(2006)HumanMolecularGeneticsTra-1-81Tra-1-60SSEA-4SSEA-1Oct4APKbufferfeederPositivecontrolheatHES(P20)heatTelomeraseactivityinhEScellsSun,etal.UndifferentiatedEScolony
semi-differentiatedEScolony
differentiatedEScolony(AKPpositive)(AKPnegative)(AKPmixture)OverexpressionofStk40couldreduceEScellself-renewalabilityColonyformingassayonstk40overexpressedEScellsStk40overexpressedandcontrolcellswereplatedon100mmdishataverylowdensityandculturedforabout1weeks.TheESCcolonieswerefixed,stainedwithAKP(alkalinephosphatase)andcountedaccordingthreedifferenttypes.Ivanova,Netal.Nature442:533,2006AcompetitionstrategyRegulationofembryonicstemcellself-renewalandpluripotencybyleukaemiainhibitoryfactorHiroyukiHirai,PeterKarian,andNobuakiKikyo1Pluripotency
*EmbryoidBody(EB)formation,invitro;*Teratomaformation,invivo;*Developmentalpotentialinchimericoffspring.EmbryoidBody擬胚體(EB)Todate,thebest-studiedmodeofEScelldifferentiationistheformationinsuspensioncultureofmulti-cellularaggregates聚集calledEBs.Withintheseaggregates,complexinteractionsbetweenheterologouscelltypesresultintheinductionofdifferentiationofstemcellstoderivativesofallthreeembryonicgermlayers.PlatingoftheEBscausesfurtherdifferentiationandoutgrowth.
A.G.Smith,2003SimpleEBCysticEBAEBbulgesoutOutgrowthfromanEBSun,etal.hESEBd3EBd13EBd18EBofhESCells
InvitrodifferentiationassayPluripotency
*EmbryoidBody(EB)formation,invitro;*Teratomaformation,invivo;*Developmentalpotentialinchimaericoffspring.Pluripotency
*EmbryoidBody(EB)formation,invitro;*Teratomaformation,invivo;*Developmentalpotentialinchimeric嵌合體offspring.
DeterminationofdevelopmentalpotentialofEScellsEScellscontributetodifferentcelltypes,includinggermlinecells,inchimericoffspring.Embryonicstemcelltrialsformaculardegeneration:apreliminaryreportTheLancet(2012)StevenDSchwartz,Jean-PierreHubschman,GadHeilwell,ValentinaFranco-Cardenas,CarolynKPan,RosaleenMOstrick,EdmundMickunas,RogerGay,IrinaKlimanskaya,RobertLanzaInterpretationThehESC-derivedRPEcellsshowednosignsofhyperproliferation,tumorigenicity,ectopictissueformation,orapparentrejectionafter4months.Thefuturetherapeuticgoalwillbetotreatpatientsearlierinthediseaseprocesses,potentiallyincreasingthelikelihoodofphotoreceptorandcentralvisualrescue.LANCET,201418patients22monthfollowupVisualacuityImprovedin10Remainedsamein7Decreasedin1StemCellReportsMay12,20154Asianpatients1yearfollowupVisualacuityImprovedin3Remainedstablein1ChallengesofapplicationofhESC-derivedcells:功能細(xì)胞,動(dòng)物模型,安全問題,免疫排斥★Functionalcellsimmaturepancreaticendocrinecells未成熟胰腺內(nèi)分泌細(xì)胞,造血干細(xì)胞在卵黃囊中是相似的,;Hematopoieticstemcells(HSCs)resemblingthoseoftheyolksac;hepatocyteshavinganembryonicidentity.Longcultureinvitro(between45daysandupto3months).★Animalmodelsforspecificdiseasesandrobustinvitrofunctionaltests動(dòng)物模型對(duì)于特定疾病★Safetyissues
animalcomponents:mousefeedercells,fetalbovineSerumtumorformation:undifferentiatedorpartiallydifferentiatedESCs,heterogeneouspopulations,karyotypicinstability.★Immuno-rejection
Solutions:促進(jìn)分化流程,保證多能干細(xì)胞不參與,流式純化特定標(biāo)志,包含選擇性基因★Improvedifferentiationprotocolsforgenerationofhomogenouspopulationoffullydifferentiatedcells;★
Guaranteetheabsenceofpluripotentcellsintransplantedcells:
◆purificationbyFACSusingspecificcell-surfacemakers;
◆
hESCscanbeengineeredtocontainaselectiongeneContents★
Concept
★
EmbryonicStemCells
★Reprogramming(重編程)
TheNobelPrizeinPhysiologyorMedicine2012SirJohnB.GurdonSirJohnB.GurdonBorn:1933,Dippenhall,UnitedKingdomAffiliationatthetimeoftheaward:GurdonInstitute,Cambridge,UnitedKingdomPrizemotivation:"forthediscoverythatmaturecellscanbereprogrammedtobecomepluripotent"AclassicexperimentItwaswhilehewasatOxford'sDepartmentofZoologythathecarriedoutaclassicexperimentpublishedin1962.Hehypothesizedthatthegenomeofamaturecellmightstillcontainalltheinformationneededtodriveitsdevelopmentintoallthedifferentcelltypesofanorganism.Hereplacedtheimmaturecellnucleusinaneggcellofafrogwiththenucleusfromamatureintestinalcell.Thismodifiedeggcelldevelopedintoanormaltadpole.TheDNAofthematurecellstillhadalltheinformationneededtodevelopallcellsinthefrog.Cloning'becameareality’ProfessorChrisGrahamofOxfordUniversity'sDepartmentofZoology,oneofSirJohn'sfirststudentswhoworkedwithhimatOxfordinthe1960s,says:'Heshowedthatyoucouldtakeseveralnucleifromoneindividualandproducegenetically-identicalanimals–thatwashisgreatachievement.PeoplehadtalkedaboutcloningagooddealbutwithJohnGurdon’sworkitbecameareality.1997NatureDollyisderivedfromamammaryglandcellTherapeuticCloningReproductiveCloningCibelli,2003Science33:1669,2004Science2004核移植
孤雌發(fā)育2007ByLifelineCellTechnology,USAandScientificCenterforObstetrics,Gynecology,andPerinatology,RussiaHumanEmbryonicStemCellsDerivedbySomaticCellNuclearTransfer1DivisionofReproductive&DevelopmentalSciences,OregonNationalPrimateResearchCenter,OregonHealth&ScienceUniversityCELL,2013Received:April30,2013Revised:May3,2013Accepted:May3,2013Published:May15,2013InvitroactivationoocyteoocyteDifferentiatedsomaticcellsPluripotentEmbryoniccells?ProgramReprogramInducedPluripotentStemCellsiPSCells(誘導(dǎo)性多能干細(xì)胞)成纖維細(xì)胞中轉(zhuǎn)入關(guān)鍵基因,得到iPS細(xì)胞Oct4Sox2Klf4c-Myc小鼠成纖維細(xì)胞TheNobelPrizeinPhysiologyorMedicine2012Cell126,1-14,August252006Cell,誘導(dǎo)性多能干細(xì)胞
Oct-4Sox2C-MycKlf4EBsanddifferentiationTeratomasectionImmunostaininginteratomaE13.5E7.5ContributionofiPScellstomouseembryonicdevelopment2/183/22Retroinfection;Nochimaericmicewereborn;Lowefficiency;GeneexpressionandepigeneticallydifferentfromEScellsThefirstgenerationofmouseiPScellsNature2007JulyYearof2007GenerationofOct4-andNanog-selectediPScells.Oct4locus6weeksChimericmouseb,c:twolivepupsafter2Nblastocystinjection;d:iPSembryosbyinjectioninto4Nblastocyst;E12.5e:E14.5embryofrom4NTetraploidBlastocystComplementationFromShaorongGaoinTongjiUniversityOct4-andNanog-selection;Viablechimaeras;Contributetogermline;Generatelivelate-termembryoswheninjectedintotetraploidblastocysts;ThebiologicalpotencyandepigeneticstateareindistinguishablefromthoseofEScellsThesecondgenerationofmouseiPScellsNature2007JulyChimericmaleXC57BL/6femaleTumorformationbyc-Mycreactivation121F1mice(8-41weeks)fromNanog-iPS20D17cellline;24diedorwerekilledduetoillness;13miceidentifiednecktumors,5micewithothertumors;20%Inthesetumors,retroviralexpressionofc-Mycisreactivated.NatureBiotechnology,2007OctoberNat.Biotech,2008129SvJae/C57B6/LE14.5ChimerasTheefficiencyforderivingiPScellsfromthenumberofpickedcolonieswasabout45%.Theoverallefficiencyofreprogrammingwasabout0.5%5-10timeshigherthanwhathasbeenachievedwiththedrug-selectionapproaches.ThethirdgenerationofmouseiPScellsYear2009Bygroupsof1.JamesThomsonpublishedinScience(Oct4,Sox2,NanogandLin28)withlentivirus
2.ShinyaYamanakapublishedinNatureBiotec.(Oct4,Sox2,Klf4andc-Myc)withretrovirus
3.GeorgeDaleypublishedinNature(Oct4,Sox2,Klf4,c-Myc,SV40largeT,hTERT)Yearof2007TreatmentofSicklecellanemiamousemodelwithiPScellsGeneratedfromautologousskinbyRudolfJaenischgroupScience
2007December鐮狀細(xì)胞性貧血transductionstrategyandfactorselectiondonorcellresourceselectionandcharacterizationmethodsapplicationofiPScellsKeystepsofestablishingiPScelllines重編程來源細(xì)胞表皮成纖維細(xì)胞:細(xì)胞數(shù)量多,重編程技術(shù)成熟,難以采集。外周血單核細(xì)胞:便于采集(醫(yī)院),不易污染。腎小管上皮細(xì)胞:便于采集(新鮮中段尿液中收集,對(duì)提供者不造成損傷)。附加體質(zhì)粒(episomalplasmid)
重編程技術(shù)病毒轉(zhuǎn)染:造成插入突變蛋白質(zhì)誘導(dǎo):低效,操作復(fù)雜小分子誘導(dǎo):目前尚不適用于人體細(xì)胞附加體質(zhì)粒轉(zhuǎn)染:相對(duì)高效,易于操作,不整合外源基因,適用于多種體細(xì)胞(表皮成纖維細(xì)胞、外周血單核細(xì)胞、腎小管上皮細(xì)胞等)Sendai病毒附加體質(zhì)粒(episomalplasmid)重編程技術(shù)皮膚成纖維細(xì)胞來源的iPSC系A(chǔ)pplicationofiPScells★
Cellreplacementtherapy★
Studydiseases★
ScreenfordrugsEssentialstep:
DifferentiationiPS細(xì)胞誕生的重要意義解決免疫排斥問題;避開ESC建系的倫理問題;疾病發(fā)生的個(gè)體特異性;治療的個(gè)體化。分化全能重編程建立患者特異的疾病模型研究疾病發(fā)生機(jī)制藥物篩選和個(gè)體性治療基因改造正常細(xì)胞病變細(xì)胞自我更新非遺傳性疾病遺傳性疾病細(xì)胞替代治療DiseaseiPScelllinesSpinalmuscularatrophy(Nature,2008)Amyotrophiclateralsclerosis(ALS)(Science2008)Parkison’sdiseasepatient(Cell,2009)Type1diabetes(PNAS,2009)Fanconianemia(Nature,2009)Dysautonomia(Nature,2009)家族性自主神經(jīng)異常Amyotrophiclateralsclerosis(ALS,Science,2009)Klinefeltersyndrome,47,XXYanditsvariants,isthemostcommonchromosomalaberrationamongmen,withestimatedfrequencyof1:500amongnewborns.MenwithKlinefeltersyndromepresentwithsequelsofhor
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度智慧城市承建合同標(biāo)的城市信息化建設(shè)4篇
- 2025年京都議定書碳排放權(quán)減排項(xiàng)目融資與ESG審計(jì)合同3篇
- 2025年度生態(tài)修復(fù)工程純勞務(wù)分包合同范本4篇
- 2024智能交通工具研發(fā)合同
- 2024藝團(tuán)藝人團(tuán)體管理簽約合同3篇
- 2025年度新能源打井工程合作框架協(xié)議3篇
- 如何編寫仿古磚項(xiàng)目可行性研究報(bào)告
- 2025年洗滌設(shè)備品牌授權(quán)與合作合同協(xié)議書范本3篇
- 2025年度環(huán)保工程設(shè)計(jì)個(gè)人勞務(wù)承包合同4篇
- 2025年新能源汽車租賃企業(yè)間聯(lián)營合同3篇
- 巖土工程勘察課件0巖土工程勘察
- 《腎上腺腫瘤》課件
- 2024-2030年中國典當(dāng)行業(yè)發(fā)展前景預(yù)測及融資策略分析報(bào)告
- 《乘用車越野性能主觀評(píng)價(jià)方法》
- 幼師個(gè)人成長發(fā)展規(guī)劃
- 2024-2025學(xué)年北師大版高二上學(xué)期期末英語試題及解答參考
- 動(dòng)物醫(yī)學(xué)類專業(yè)生涯發(fā)展展示
- 批發(fā)面包采購合同范本
- 乘風(fēng)化麟 蛇我其誰 2025XX集團(tuán)年終總結(jié)暨頒獎(jiǎng)盛典
- 2024年大數(shù)據(jù)分析公司與中國政府合作協(xié)議
- 一年級(jí)數(shù)學(xué)(上)計(jì)算題專項(xiàng)練習(xí)匯編
評(píng)論
0/150
提交評(píng)論